Literature DB >> 15665069

Development of a set of strategy-based system-level cancer care performance indicators in Ontario, Canada.

Anna Greenberg1, Helen Angus, Terrence Sullivan, Adalsteinn D Brown.   

Abstract

OBJECTIVES: To develop a set of scientifically sound and managerially useful system-level cancer care performance indicators for public reporting in Ontario, Canada. IMPLEMENTATION: Using a modified Delphi panel method, comprising a systematic literature review and multiple rounds of structured feedback from 34 experts, the Cancer Quality Council of Ontario developed a set of quality indicators spanning cancer prevention through to end-of-life care. To be useful to decision-makers and providers, indicator selection criteria included a clear focus on the cancer system, relevance to a diversity of cancer providers, a strong link to the mission and strategic objectives of the cancer system, clear directionality of indicator results, presence of targets and/or benchmarks, feasibility of populating the indicator, and credibility of the measure as an indicator of quality. To ensure that the selected indicators would measure progress over time against specific and widely accepted goals, we created a strategy map based on the five strategic objectives of the Ontario cancer system: (i) to improve the measurement and reporting of cancer quality, (ii) to increase the use of evidence and innovation in decision-making, (iii) to improve access to cancer services and reduce waiting times, (iv) to increase efficiency across the system, (v) to reduce the burden of cancer. An analysis of the mean indicator ratings by experts, and the strategy mapping exercise resulted in the identification of 36 indicators deemed suitable for routine performance measurement of the Ontario cancer system. LESSONS LEARNED: The resulting instrument incorporates a credible evidence basis for performance measurement aligned to the five strategic goals for the Ontario cancer system. It represents the integrating of a management culture, focused on the implementation of a new strategic direction for the cancer system, with the underlying evidence-based culture of clinicians.

Entities:  

Mesh:

Year:  2005        PMID: 15665069     DOI: 10.1093/intqhc/mzi007

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  21 in total

1.  Determinants of oral cancer at the national level: just a question of smoking and alcohol drinking prevalence?

Authors:  Stefano Petti; Crispian Scully
Journal:  Odontology       Date:  2010-07-23       Impact factor: 2.634

2.  Waiting for cancer care: exploiting our national laboratory.

Authors:  Terrence Sullivan
Journal:  Can J Surg       Date:  2006-02       Impact factor: 2.089

3.  Models that work: incorporating quality principles in different clinical settings.

Authors:  Monika K Krzyzanowska; Douglas W Blayney; Linda D Bosserman; Terrence James Sullivan
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

4.  Making health system performance measurement useful to policy makers: aligning strategies, measurement and local health system accountability in ontario.

Authors:  Jeremy Veillard; Tai Huynh; Sten Ardal; Sowmya Kadandale; Niek S Klazinga; Adalsteinn D Brown
Journal:  Healthc Policy       Date:  2010-02

5.  Quality measures for medication continuity in long-term care facilities, using a structured panel process.

Authors:  Chaim M Bell; Stacey S Brener; Rebecca Comrie; Geoffrey M Anderson; Susan E Bronskill
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

6.  The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.

Authors:  Madhur Nayan; Michael A S Jewett; Lynn Anson-Cartwright; Philippe L Bedard; Malcolm Moore; Peter Chung; Padraig Warde; Joan Sweet; Martin O'Malley; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

7.  Selecting high priority quality measures for breast cancer quality improvement.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Rebecca Ottesen; Stephen B Edge; Michael A Bookman; Robert W Carlson; Richard L Theriault; Jane C Weeks
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

8.  The Delphi process: a solution for reviewing novel grant applications.

Authors:  Cath Holliday; Monica Robotin
Journal:  Int J Gen Med       Date:  2010-08-30

9.  Identification of performance indicators across a network of clinical cancer programs.

Authors:  S R Khare; G Batist; G Bartlett
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

10.  Defining research priorities for pancreatic cancer in Australia: results of a consensus development process.

Authors:  Monica C Robotin; Sandra C Jones; Andrew V Biankin; Louise Waters; Don Iverson; Helen Gooden; Bruce Barraclough; Andrew G Penman
Journal:  Cancer Causes Control       Date:  2010-01-14       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.